JYNT JOINT Corp

Nasdaq thejoint.com


$ 7.81 $ 0.14 (1.83 %)    

Monday, 10-Nov-2025 15:59:54 EST
QQQ $ 620.23 $ 0.00 (0 %)
DIA $ 473.88 $ 0.00 (0 %)
SPY $ 679.64 $ 0.00 (0 %)
TLT $ 89.47 $ 0.00 (0 %)
GLD $ 380.32 $ 0.00 (0 %)
$ 7.81
$ 7.75
$ 7.64 x 1
$ 8.35 x 1
-- - --
$ 7.50 - $ 13.47
154,114
na
116.1M
$ 1.52
$ 60.04
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-14-2025 12-31-2024 10-K
5 11-08-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 03-08-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 09-26-2023 06-30-2023 10-Q
11 05-05-2023 03-31-2023 10-Q
12 03-10-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 03-12-2022 12-31-2021 10-K
17 11-05-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 03-05-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-07-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-06-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 03-11-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-10-2018 06-30-2018 10-Q
31 05-11-2018 03-31-2018 10-Q
32 03-09-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-11-2017 06-30-2017 10-Q
35 05-12-2017 03-31-2017 10-Q
36 03-10-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-12-2016 06-30-2016 10-Q
39 05-16-2016 03-31-2016 10-Q
40 03-17-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 joint-q3-eps-006-beats-005-estimate-sales-13381m-beat-13360m-estimate

Joint (NASDAQ:JYNT) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 25 per...

 b-riley-securities-maintains-buy-on-joint-lowers-price-target-to-18

B. Riley Securities analyst Jeff Van Sinderen maintains Joint (NASDAQ:JYNT) with a Buy and lowers the price target from $20 ...

 joint-corp-says-it-expects-to-restate-fy24-and-q1-2025-financial-statements-due-to-overestimated-noncash-impairment-charges

- SEC Filing 

 the-joint-sells-31-clinics-for-83m-gains-control-of-profitable-northwest-franchise-region

The Joint Corp. (NASDAQ:JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network...

 the-joint-sells-31-clinics-to-largest-franchisee-expands-northwest-territory-ahead-of-june-30-deal-close

The Joint Corp. (NASDAQ:JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network...

 the-joint-corp-approves-5m-stock-buyback-program-starting-august-2025

The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, ...

 lake-street-maintains-buy-on-joint-lowers-price-target-to-16

Lake Street analyst Ryan Meyers maintains Joint (NASDAQ:JYNT) with a Buy and lowers the price target from $20 to $16.

 joint-q1-eps-005-beats-001-estimate-sales-1308m-beat-1302m-estimate

Joint (NASDAQ:JYNT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.01 by 400 pe...

 the-joint-corp-sees-fy25-system-wide-sales-550m-570m

2025 GuidanceThe company provided the following guidance for 2025.System-wide sales are expected to be between $550 million and...

 joint-q4-eps-018-misses-001-estimate-sales-1445m-miss-2899m-estimate

Joint (NASDAQ:JYNT) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $0.01 by 1900...

 the-joint-corp-performed-147m-patient-visits-in-2024-compared-to-136m-in-2023

2024 Full Year Operating HighlightsPerformed 14.7 million patient visits, compared to 13.6 million in 2023.Treated 957,000 new ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION